Eric Rubin

== Education and career ==

== Education and career ==

Rubin graduated from [[Brockton High School]], [[Harvard College]] (AB, 1980) and [[Tufts University]] (MD and PhD, 1990).{{cite web | title=Brockton native named editor-in-chief of NE Journal of Medicine | url=https://www.enterprisenews.com/story/news/local/2019/06/23/brockton-native-named-editor-in/4847232007/ }} As a graduate student he studied the mechanism of action of botulinum toxins with Dr. Michael Gill.{{cite web |title=Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Roster |url=https://www.fda.gov/media/155882/download |website=U.S. Food and Drug Administration |publisher=U.S. Department of Health and Human Services |date=2021-10-14 |access-date=2024-12-27}} Rubin trained in Internal Medicine and Infectious Disease at the [[Massachusetts General Hospital]]{{cite web | title=Dr. Eric J Rubin, MD, PhD - Boston, MA - Infectious Diseases - Request Appointment | url=https://doctors.massgeneralbrigham.org/provider/eric-j-rubin/254559 }} and went on to postdoctoral work in [[John Mekalanos]]{{cite web | title=Alumni - Mekalanos Lab | url=https://mekalanoslab.med.harvard.edu/alumni/ }} lab at [[Harvard Medical School]]. There he studied [[Vibrio cholerae]], Haemophilus influenzae and Mycobacterium smegmatis. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.{{cite web | title=U.S. Patent for Hyperactive mutants of Himar1 transposase and methods for using the same Patent (Patent # 6,368,830 issued April 9, 2002) - Justia Patents Search | url=https://patents.justia.com/patent/6368830 }}

Rubin graduated from [[Brockton High School]], [[Harvard College]] (AB, 1980) and [[Tufts University]] (MD and PhD, 1990).{{cite web | title=Brockton native named editor-in-chief of NE Journal of Medicine | url=https://www.enterprisenews.com/story/news/local/2019/06/23/brockton-native-named-editor-in/4847232007/ }} As a graduate student he studied the mechanism of action of botulinum toxins with Dr. Michael Gill.{{cite web |title=Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Roster |url=https://www.fda.gov/media/155882/download |website=U.S. Food and Drug Administration |publisher=U.S. Department of Health and Human Services |date=2021-10-14 |access-date=2024-12-27}} Rubin trained in Internal Medicine and Infectious Disease at the [[Massachusetts General Hospital]]{{cite web | title=Dr. Eric J Rubin, MD, PhD - Boston, MA - Infectious Diseases - Request Appointment | url=https://doctors.massgeneralbrigham.org/provider/eric-j-rubin/254559 }} and went on to postdoctoral work in [[John Mekalanos]]{{cite web | title=Alumni - Mekalanos Lab | url=https://mekalanoslab.med.harvard.edu/alumni/ }} lab at [[Harvard Medical School]]. There he studied [[Vibrio cholerae]], [[Haemophilus influenzae]] and [[Mycobacterium smegmatis]]. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.{{cite web | title=U.S. Patent for Hyperactive mutants of Himar1 transposase and methods for using the same Patent (Patent # 6,368,830 issued April 9, 2002) - Justia Patents Search | url=https://patents.justia.com/patent/6368830 }}

Rubin joined the Department of Immunology and Infectious Diseases at the [[Harvard T.H. Chan School of Public Health]] in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department.{{cite web | title=Harvard Public Health Magazine | Home | url=https://www.hsph.harvard.edu/magazine/magazine_article/scientist-at-work-scientist-at-play/ }} His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study [[Mycobacterium tuberculosis]] and related organisms.{{cite web | title=Rubin Lab | Harvard T.H. Chan School of Public Health | date=June 29, 2024 | url=https://hsph.harvard.edu/research/rubin-lab/ }} With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development.{{cite web | title=Rubin Lab | Harvard T.H. Chan School of Public Health | date=June 29, 2024 | url=https://www.hsph.harvard.edu/rubin-lab/research/ }} He is also an infectious disease clinician who sees patients at [[Brigham and Women’s Hospital]], where he is an Associate Physician.

Rubin joined the Department of Immunology and Infectious Diseases at the [[Harvard T.H. Chan School of Public Health]] in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department.{{cite web | title=Harvard Public Health Magazine | Home | url=https://www.hsph.harvard.edu/magazine/magazine_article/scientist-at-work-scientist-at-play/ }} His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study [[Mycobacterium tuberculosis]] and related organisms.{{cite web | title=Rubin Lab | Harvard T.H. Chan School of Public Health | date=June 29, 2024 | url=https://hsph.harvard.edu/research/rubin-lab/ }} With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development.{{cite web | title=Rubin Lab | Harvard T.H. Chan School of Public Health | date=June 29, 2024 | url=https://www.hsph.harvard.edu/rubin-lab/research/ }} He is also an infectious disease clinician who sees patients at [[Brigham and Women’s Hospital]], where he is an Associate Physician.